MERGERS & ACQUISITIONS
Remgro’s Mediclinic blunder
Cheeky is a nice way to describe Remgro’s bid to buy out the hospital group’s minorities. It will need to cough up if it is to win over the market
Remgro should know better. If the JSE’s largest investment company is serious about restructuring its portfolio to close a frustrating market discount, then perhaps it should not be pitching opportunistic buyout offers to minority shareholders in Mediclinic International.
But if a deal eventually does come off, Remgro will be taking a huge step towards reinventing itself as a compelling hub of top-quality unlisted investments...